Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2699-2706.
Prepublished online as a Blood First Edition Paper on December 7, 2004; DOI 10.1182/blood-2004-07-2648.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-07-2648v1
105/7/2699    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by von Kalle, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by von Kalle, C.
Related Collections
Right arrow Immunotherapy
Right arrow Gene Therapy
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

GENE THERAPY

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial

Manfred Schmidt, Salima Hacein-Bey-Abina, Manuela Wissler, Frederique Carlier, Annick Lim, Claudia Prinz, Hanno Glimm, Isabelle Andre-Schmutz, Christophe Hue, Alexandrine Garrigue, Francoise Le Deist, Chantal Lagresle, Alain Fischer, Marina Cavazzana-Calvo, and Christof von Kalle

From the Department of Internal Medicine, University of Freiburg, Germany; Institute of Molecular Medicine and Cell Research, University of Freiburg, Germany; Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 429, Hôpital Necker, Paris, France; Department of Biotherapy AP-HP, Hôpital Necker, Paris, France; Unité de Biologie Moléculaire du Gène, INSERM U277, Institut Pasteur, Paris, France; Laboratoire d'Immunologie Pédiatrique, AP-HP, Hôpital Necker, Paris, France; Unité d'Immunologie et d'Hématologie Pédiatriques, Hôpital Necker, Paris, France; and Department of Experimental Hematology, Children's Hospital Research Foundation, Cincinnati, OH.

Immune function has been restored in 9 of 10 children with X-linked severe combined immunodeficiency by {gamma}c gene transfer in CD34+ cells. The distribution of both T-cell receptor (TCR) V{beta} family usage and TCR V{beta} complementarity-determining region 3 (CDR3) length revealed a broadly diversified T-cell repertoire. Retroviral integration site analysis in T cells demonstrated a high number of distinct insertion sites, indicating polyclonality of genetically corrected cell clones, in all patients. Detection of {gamma}c transgene expression on patients' mature myeloid cells has prompted us to investigate the nature of the most immature transduced hematopoietic precursor cells. Insertion sites shared by T and B lymphocytes as well as highly purified granulocytes and monocytes demonstrate the correction of common multipotent progenitor cells. Moreover, our data show that differentiated leukocytes share the same exact insertion sites with CD34+ cells that we obtained 8 months later and that were able to generate long-term culture-initiating cells (LTC-ICs). This finding demonstrates the initial transduction of very primitive multipotent progenitor cells with self-renewal capacity. These results provide a first evidence in the setting of a clinical trial that CD34+ cells maintain both lymphomyeloid potential as well as self-renewal capacity after ex vivo manipulation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
F. Zhang, S. I. Thornhill, S. J. Howe, M. Ulaganathan, A. Schambach, J. Sinclair, C. Kinnon, H. B. Gaspar, M. Antoniou, and A. J. Thrasher
Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
Blood, September 1, 2007; 110(5): 1448 - 1457.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Chinen, J. Davis, S. S. De Ravin, B. N. Hay, A. P. Hsu, G. F. Linton, N. Naumann, E. Y. H. Nomicos, C. Silvin, J. Ulrick, et al.
Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency
Blood, July 1, 2007; 110(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Yahata, S. Yumino, Y. Seng, H. Miyatake, T. Uno, Y. Muguruma, M. Ito, H. Miyoshi, S. Kato, T. Hotta, et al.
Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cells
Blood, October 1, 2006; 108(7): 2446 - 2454.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L. Gammaitoni, S. Lucchi, S. Bruno, M. Tesio, M. Gunetti, Y. Pignochino, G. Migliardi, L. Lazzari, M. Aglietta, P. Rebulla, et al.
Serial Transplantations in Nonobese Diabetic/Severe Combined Immunodeficiency Mice of Transduced Human CD34+ Cord Blood Cells: Efficient Oncoretroviral Gene Transfer and Ex Vivo Expansion Under Serum-Free Conditions
Stem Cells, May 1, 2006; 24(5): 1201 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Crise, Y. Li, C. Yuan, D. R. Morcock, D. Whitby, D. J. Munroe, L. O. Arthur, and X. Wu
Simian Immunodeficiency Virus Integration Preference Is Similar to That of Human Immunodeficiency Virus Type 1
J. Virol., October 1, 2005; 79(19): 12199 - 12204.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Deisseroth
Normal and pathological functions of mammalian retroelements
PNAS, August 30, 2005; 102(35): 12292 - 12293.
[Full Text] [PDF]


Home page
BloodHome page
A. J. Thrasher, S. Hacein-Bey-Abina, H. B. Gaspar, S. Blanche, E. G. Davies, K. Parsley, K. Gilmour, D. King, S. Howe, J. Sinclair, et al.
Failure of SCID-X1 gene therapy in older patients
Blood, June 1, 2005; 105(11): 4255 - 4257.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020